Scientists work toward a Chlamydia vaccine

Jul 25, 2006

U.S. scientists studying how the immune system responds to genital tract infections are using a mouse model to track immunity against Chlamydia.

The Harvard Medical School researchers say their findings might hasten the development of vaccines for Chlamydia -- the most common cause of bacterial sexually transmitted disease in the United States.

"Right now Chlamydia is sensitive to treatment with antibiotics," said Michael Starnbach, associate professor of microbiology and molecular genetics. "But the problem is that many people have 'silent' infections that remain untreated,

"These undiagnosed infections, over time, lead to complications like tubal pregnancy and infertility. The goal would be to vaccinate young people to keep them from suffering from undiagnosed infection and the bad outcomes associated with it."

The study -- funded by the National Institutes of Health -- appears in the early online edition of the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: Classes aim to hook US blacks on African foods

add to favorites email to friend print save as pdf

Related Stories

The mathematics of chlamydia's spread

Feb 03, 2014

(Phys.org) —It sounds an unlikely pairing: using maths to combat the spread of a sexually transmitted disease that can lead to infertility, but a group of mathematicians has delivered a solution that enables ...

Seniors' sex lives are up -- and so are STD cases

May 17, 2011

Across the nation, and especially in communities that attract a lot of older Americans, the free-love generation is continuing to enjoy an active - if not always healthy - sex life.

Alaska ranks No. 1 for chlamydia

May 05, 2011

Alaska again ranks first in the nation for chlamydia and is second for gonorrhea, state public health officials announced Tuesday.

Recommended for you

Early hormone therapy may be safe for women's hearts

18 minutes ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Human brain has coping mechanism for dehydration

48 minutes ago

(HealthDay)—Although dehydration significantly reduces blood flow to the brain, researchers in England have found that the brain compensates by increasing the amount of oxygen it extracts from the blood. ...

Low yield for repeat colonoscopy in some patients

58 minutes ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

User comments : 0